France Prostate Cancer Diagnostic and Therapeutic Market to Witness Robust Expansion by 2025

France prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The country is among the most susceptible to the prostate cancer in Europe. As per the World Health Organization, around 25% of the overall cancer cases are of prostate cancer, which is around 65,000 in 2018. The 5-year prevalence in the country due to prostate cancer is around 228,000 in 2018. In the country, obesity is one of the major factors of prostate cancer. The country has a high consumption of alcohol, smoking, a high level of animal fat consumption, serum total cholesterol and high-density lipoprotein cholesterol concentrations. Due to this, individuals are more prone to becoming obese increasing their chances of being affected with prostate cancer.

(Get 25% Discount on Buying this Report)

To Request a Sample of our Report on France Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/france-prostate-cancer-diagnostic-therapeutic-market

Government initiatives for prostate cancer management are one of the factors augmenting the demand for prostate cancer diagnostic and therapeutic. France government has been actively supporting the healthcare system with most of the chronic diseases, 100% covered by French statuary health insurance. The healthcare system in France is one of the universal healthcare majorly financed by government national health insurance. The state covers the healthcare costs of residents not eligible for Statuary Health Insurance (SHI). The state also covers illegal immigrants who have applied for residency, as well as residents from the EU. Non-EU visitors are covered for emergency services only.

A full Report of France Prostate Cancer Diagnostic and Therapeutic Market is Available @ https://www.omrglobal.com/industry-reports/france-prostate-cancer-diagnostic-therapeutic-market

France Prostate Cancer Diagnostic and Therapeutic Market Segmentation

By Diagnostic Techniques

· Prostate-Specific Antigen Test (PSA)

· Digital Rectal Examination

· Prostate Biopsy

· Imaging Techniques

By Therapeutics

· Hormonal Therapy

· Chemotherapy

· Immunotherapy

· Radiation Therapy

· Targeted Therapy

· Surgery

Company Profiles

· Abbott Laboratories

· AbbVie Products, LLC

· Amgen Inc.

· AstraZeneca PLC

· Bayer AG

· Bristol-Myers Squibb Co.

· Ferring Pharmaceuticals Inc.

· GlaxoSmithKline PLC

· Johnson & Johnson

· Pfizer Inc.

· Siemens Healthcare AG

· Ipsen Group

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.